GREENLAND MINES LTD (GRML) Fundamental Analysis & Valuation

NASDAQ:GRML • US49876K1034

Current stock price

0.4 USD
-0.02 (-4.76%)
At close:
0.4058 USD
+0.01 (+1.45%)
Pre-Market:

This GRML fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. GRML Profitability Analysis

1.1 Basic Checks

  • GRML had negative earnings in the past year.
  • GRML had a negative operating cash flow in the past year.
  • The reported net income has been mixed in the past 5 years: GRML reported negative net income in multiple years.
  • GRML had a negative operating cash flow in each of the past 5 years.
GRML Yearly Net Income VS EBIT VS OCF VS FCFGRML Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 2025 0 -2M -4M -6M -8M -10M

1.2 Ratios

  • GRML's Return On Assets of -109.99% is on the low side compared to the rest of the industry. GRML is outperformed by 78.10% of its industry peers.
  • GRML has a Return On Equity (-111.50%) which is in line with its industry peers.
Industry RankSector Rank
ROA -109.99%
ROE -111.5%
ROIC N/A
ROA(3y)-117.78%
ROA(5y)N/A
ROE(3y)-206.13%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
GRML Yearly ROA, ROE, ROICGRML Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 2025 0 -100 -200 -300 -400 -500

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for GRML so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
GRML Yearly Profit, Operating, Gross MarginsGRML Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 2025

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

8

2. GRML Health Analysis

2.1 Basic Checks

  • Compared to 1 year ago, GRML has more shares outstanding
  • GRML has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
GRML Yearly Shares OutstandingGRML Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 2025 20M 40M 60M
GRML Yearly Total Debt VS Total AssetsGRML Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M

2.2 Solvency

  • GRML has an Altman-Z score of 219.54. This indicates that GRML is financially healthy and has little risk of bankruptcy at the moment.
  • GRML has a Altman-Z score of 219.54. This is amongst the best in the industry. GRML outperforms 99.22% of its industry peers.
  • There is no outstanding debt for GRML. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 219.54
ROIC/WACCN/A
WACCN/A
GRML Yearly LT Debt VS Equity VS FCFGRML Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 2025 0 20M 40M 60M 80M 100M

2.3 Liquidity

  • GRML has a Current Ratio of 94.97. This indicates that GRML is financially healthy and has no problem in meeting its short term obligations.
  • GRML's Current ratio of 94.97 is amongst the best of the industry. GRML outperforms 99.81% of its industry peers.
  • A Quick Ratio of 94.97 indicates that GRML has no problem at all paying its short term obligations.
  • GRML has a Quick ratio of 94.97. This is amongst the best in the industry. GRML outperforms 99.81% of its industry peers.
Industry RankSector Rank
Current Ratio 94.97
Quick Ratio 94.97
GRML Yearly Current Assets VS Current LiabilitesGRML Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 2025 2M 4M 6M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

0

3. GRML Growth Analysis

3.1 Past

  • GRML shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 17.27%, which is quite good.
EPS 1Y (TTM)17.27%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%75.89%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocksShow best growing peers

0

4. GRML Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for GRML. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
GRML Price Earnings VS Forward Price EarningsGRML Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
GRML Per share dataGRML EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.1 -0.2

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. GRML Dividend Analysis

5.1 Amount

  • No dividends for GRML!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

GRML Fundamentals: All Metrics, Ratios and Statistics

GREENLAND MINES LTD

NASDAQ:GRML (4/10/2026, 8:28:04 PM)

Premarket: 0.4058 +0.01 (+1.45%)

0.4

-0.02 (-4.76%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)03-31
Earnings (Next)05-15
Inst Owners3.68%
Inst Owner Change0.11%
Ins Owners10.33%
Ins Owner ChangeN/A
Market Cap48.50M
Revenue(TTM)N/A
Net Income(TTM)-10.55M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short Ratio0.54
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 5.12
P/tB 6.77
EV/EBITDA N/A
EPS(TTM)-0.27
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.05
FCFYN/A
OCF(TTM)-0.05
OCFYN/A
SpS0
BVpS0.08
TBVpS0.06
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -109.99%
ROE -111.5%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-117.78%
ROA(5y)N/A
ROE(3y)-206.13%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 94.97
Quick Ratio 94.97
Altman-Z 219.54
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)17.27%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%75.89%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-28.99%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-99.87%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-99.87%
OCF growth 3YN/A
OCF growth 5YN/A

GREENLAND MINES LTD / GRML Fundamental Analysis FAQ

What is the fundamental rating for GRML stock?

ChartMill assigns a fundamental rating of 3 / 10 to GRML.


What is the valuation status for GRML stock?

ChartMill assigns a valuation rating of 0 / 10 to GREENLAND MINES LTD (GRML). This can be considered as Overvalued.


How profitable is GREENLAND MINES LTD (GRML) stock?

GREENLAND MINES LTD (GRML) has a profitability rating of 1 / 10.


Can you provide the financial health for GRML stock?

The financial health rating of GREENLAND MINES LTD (GRML) is 8 / 10.